Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
B.C. Planer, R.A. Ballard, P.L. Ballard, C.E. Cobum, C. Boardmann, A. Cnaan, et al.
Antenatal corticosteroid (ANCS) use in preterm labor in the USA.
Pediatr Res, 39 (1996), pp. 110A
[2.]
S.G. Mathews.
Antenatal glucocorticoids and programming of the developing CNS.
Pediatr Res, 47 (2000), pp. 291-300
[3.]
N. Modi, H. Lewis, N. Al-naqeb, M. Ajayi-Obe, C. Doré, M. Rutherford.
The effects of repeated antenatal glucocorticoid therapy on the developing brain.
Pediatr Res, 50 (2001), pp. 581-585
[4.]
H. French, R. Hagan, S. Evans, M. Godfrey, J. Newnham.
Repeated antenatal corticosteroids: size at birth and subsequent development.
Am J Obstet Gynecol, 180 (1999), pp. 114-1121
[5.]
M. Esplin, M. Fausett, S. Smith, B.T. Oshiro, T.F. Porter, D.W. Branch, et al.
Multiple courses of antenatal steroids are associated with a delay in long-term psychomotor development in children with birth weights ≤ 1500 g.
Am J Obstet Gynecol, 182 (2000), pp. 524
[6.]
B.A. Banks, A. Cnaan, M.A. Morgan, J.T. Parer, J.D. Merril, P.L. Ballard, et al.
Multiple courses of antenatal corticosteroids and outcome of premature neonates.
Am J Obstet Gynecol, 181 (1999), pp. 709-717
[7.]
D.A. Guinn, M.W. Atkinson, L. Sillivan, M.J. Lee, S. Macgregor, B.V. Parilla, et al.
Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery. A randomized controlled trial.
Jama, 286 (2001), pp. 1581-1587
[8.]
C. McEvoy, S. Bowling, K. Williamson, D. Lozano, L. Tolaymat, L. Izquierdo, et al.
The effect of a single remote course versus weekly courses of antenatal corticosteroids on functional residual capacity in preterm infants: a randomized trial.
Pediatrics, 110 (2002), pp. 280-284
[9.]
National Institutes of Health Consensus Development Panel.
Antenatal corticosteroids revisited: repeat courses. NIH Consensus development Conference Statement, august 17–18, 2000.
Obstet Gynecol, 98 (2001), pp. 144-150
[10.]
Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin ChH, Chen JY, et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics, 1997. Disponible en: http://www.pediatrics.org/cgi/content/full/100/4/e3
[11.]
H.L. Halliday, R.A. Ehrenkranz, L.W. Doyle.
Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review).
The Cochrane Library, Issue 1,
[12.]
H.L. Halliday, R.A. Ehrenkranz, L.W. Doyle.
Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review).
The Cochrane Library, Issue 1,
[13.]
H.L. Halliday, R.A. Ehrenkranz.
Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review).
The Cochrane Library, Issue 2,
[14.]
A.R. Stark, W.A. Carlo, J.E. Tyson, L.A. Papile, L.L. Wright, S. Shankaran, et al.
Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants.
N Engl J Med, 344 (2001), pp. 95-101
[15.]
Yeh TF, Lin YJ, Huang ChC, et al.Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics, 1998. Disponible en: http://www.pediatrics.org/cgi/content/full/101/5/e7
[16.]
T.M. O'Shea, J.M. Kothadia, K.L. Klinepeter, et al.
Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.
Pediatrics, 104 (1999), pp. 15-21
[17.]
E.S. Shinwell, M. Karplus, D. Reich, et al.
Early postnatal dexamethasone treatment and increased incidence of cerebral palsy.
Arch Dis Child Fetal Neonatal Ed, 83 (2000), pp. F177-F181
[18.]
J.J. Cummings, D.B. D'Eugenio, S.J. Gross.
A controlled trial of dexamethasone in preterm infants at hihg risk for bonchopulmonary dysplasia.
N Engl J Med, 320 (1989), pp. 1505-1510
[19.]
R. Jones, E. Wincott, D. Elbourne, A. Grant.
Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up.
Pediatrics, 96 (1995), pp. 897-906
[20.]
C. Romagnoli, E. Zecca, R. Luciano, G. Torrioli, G. Tortorob.
Controlled trial of early dexamethasone for the prevention of chronic lung disease in preterm infants:a 3-year follow-up.
Pediatrics, (2002), pp. 109
[21.]
M. Durand, M.E. Mendoza, P. Tantivit, A. Kugelman, C. McEvoy.
A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation and ventilation.
Pediatrics, 109 (2002), pp. 262-268
[22.]
K.L. Watterberg, J.S. Gerdes, K.L. Gifford, H.M. Lin.
Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants.
Pediatrics, 104 (1999), pp. 1258-1263
[23.]
H.L. Halliday.
Clinical trials of postnatal corticosteroids: inhaled and systemic.
Biol Neonate, 76 (1999), pp. 29-40
[24.]
H.L. Halliday, C.C. Patterson, C.W.N.L. Halahakoon.
and European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment of dexametasone and inhaled budesonide.
Pediatrics, 107 (2001), pp. 232-240
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados